tiprankstipranks
Trending News
More News >
Bioharvest Sciences, Inc. (TSE:BHSC)
:BHSC
Canadian Market

BioHarvest Sciences (BHSC) Earnings Dates, Call Summary & Reports

Compare
40 Followers

Earnings Data

Report Date
Apr 24, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
Last Year’s EPS
Same Quarter Last Year
Based on 0 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 25, 2024
|
% Change Since: 26.19%
|
Next Earnings Date:Apr 24, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a generally positive outlook with strong revenue growth, increased gross margins, and successful expansion in both the direct-to-consumer and CDMO businesses. However, challenges remain with net losses and a diminished cash position offset by recent debt financing.
Company Guidance
In the BioHarvest Sciences fourth quarter 2024 earnings call, CEO Ilan Sobel and CFO Bar Dichter provided comprehensive guidance on the company's outlook and strategic direction. The company reported a 99% year-over-year revenue growth, reaching $25.2 million for the fiscal year 2024, with fourth-quarter revenue increasing by 62% to $7.3 million, surpassing prior guidance. Gross margins improved by 10 percentage points from the previous year, reaching 55% for the full year and 57% in Q4. Operating expenses decreased as a percentage of revenue, reflecting increased efficiencies. BioHarvest aims to achieve adjusted EBITDA profitability at approximately $11 million to $12 million in quarterly revenue, which is expected in the second half of 2025. The company plans to leverage its successful VINIA product line, which has over 50,000 subscribers, and expand into new product categories like superfood coffee and tea, which have already generated significant revenue. Additionally, BioHarvest is advancing its CDMO division, with strategic partnerships including one with Tate & Lyle for plant-based sweeteners, and aims to capitalize on its botanical synthesis technology to tackle unmet needs in the nutraceutical and pharmaceutical industries.
Strong Revenue Growth
BioHarvest Sciences reported a strong revenue growth of 99% year-over-year, achieving $25.2 million for the full year of 2024. Q4 revenue grew 62% year-over-year to $7.3 million.
Increase in Gross Margins
Gross margins for the fourth quarter of 2024 increased by 600 basis points to 57% from 51% a year ago, with a year-over-year improvement of 1,000 basis points from 45% in 2023 to 55% in 2024.
Subscription and Product Diversification Success
VINIA, the flagship product, has over 50,000 active subscribers, with 90% of Vinia.com revenue derived from subscriptions. The product lineup has expanded to include superfood coffees and teas.
Operating Leverage and Cost Management
Full year general and administrative expenses decreased by 1.8% year-over-year despite doubling the revenue base. The operating expenses decreased to 80% of revenue in Q4 2024 from 107% a year ago.
CDMO Business Expansion
BioHarvest signed multiple CDMO customers, including a marquee partnership with Tate & Lyle to develop next-generation plant-based sweeteners. Multiple deals are in the pipeline.
---

BioHarvest Sciences (TSE:BHSC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:BHSC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 24, 20252024 (Q4)
- / -
Nov 25, 20242024 (Q3)
-0.07 / -0.23
-0.173-30.06% (-0.05)
Aug 29, 20242024 (Q2)
-0.14 / -0.05
-0.28581.05% (+0.23)
May 30, 20242024 (Q1)
- / -
-0.076
Apr 30, 20242023 (Q4)
- / -0.65
-0.076-760.53% (-0.58)
Nov 29, 20232023 (Q3)
- / -0.17
-0.39255.87% (+0.22)
Aug 29, 20232023 (Q2)
- / -0.28
-0.234-21.79% (-0.05)
May 31, 20232023 (Q1)
- / -
-0.208
Apr 27, 20232022 (Q4)
- / -0.08
-0.20863.46% (+0.13)
Nov 28, 20222022 (Q3)
- / -0.39
-0.309-26.86% (-0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

TSE:BHSC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 25, 2024$6.30$6.18-1.90%
Aug 29, 2024$5.46$5.42-0.73%
May 30, 2024$6.30$6.300.00%
Apr 30, 2024$6.61$5.95-9.98%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Bioharvest Sciences, Inc. (TSE:BHSC) report earnings?
Bioharvest Sciences, Inc. (TSE:BHSC) is schdueled to report earning on Apr 24, 2025, TBA Not Confirmed.
    What is Bioharvest Sciences, Inc. (TSE:BHSC) earnings time?
    Bioharvest Sciences, Inc. (TSE:BHSC) earnings time is at Apr 24, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:BHSC EPS forecast?
          Currently, no data Available
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis